Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for SOP for pH and Osmolality Control in N…

Posted on By




SOP for pH and Osmolality Control in Nasal Formulations



Standard Operating Procedure for pH and Osmolality Control in Nasal Formulations

1) Purpose

The purpose of this SOP is to establish guidelines for controlling the pH and osmolality of nasal formulations to ensure product stability, safety, and patient comfort.

2) Scope

This SOP applies to all personnel involved in the formulation, testing, and quality control of nasal sprays and suspensions at [Company Name].

3) Responsibilities

  • Operators: Responsible for monitoring and adjusting pH and osmolality during formulation.
  • QA: Verifies that pH and osmolality meet formulation specifications and patient safety requirements.
See also  SOP for Formulating Isotonic Nasal Sprays

4) Procedure

4.1 pH Control

4.1.1 Equipment Setup

  • Ensure the pH meter is calibrated using standard buffer solutions (e.g., pH 4.0 and pH 7.0) before testing the formulation.

4.1.2 pH Adjustment

  • Measure the pH of the formulation, and if necessary, adjust the pH by adding a dilute acid (e.g., HCl) or base (e.g., NaOH) to bring it within the target range.

4.2 Osmolality Control

4.2.1 Equipment Setup

  • Ensure that the osmolality meter is calibrated and ready for use.

4.2.2 Osmolality Adjustment

  • Measure the osmolality of the formulation. If the osmolality is too high, dilute the formulation
with purified water or another isotonic solution to bring it within the desired range.

4.3 Documentation

  • Document all pH and osmolality readings, adjustments, and final values in the batch manufacturing record (BMR).
  • Ensure that QA personnel verify and sign off on all pH and osmolality measurements.

5) Abbreviations, if any

  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • pH and Osmolality Log

7) References, if any

  • ICH Q3A – Guidelines on Impurities and Stability Testing

8) SOP Version

Version 1.0

Annexure

pH and Osmolality Log Template

Date Formulation pH Osmolality (mOsm/kg) Operator Initials QA Approval
DD/MM/YYYY Formulation Name pH Value Osmolality Operator Name QA Name
           


See also  SOP for Preparing Nasal Sprays with Hydrophilic APIs
Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Monitoring Viscosity of Nasal Gels and Suspensions
Next Post: SOP for SOP for Formulation of Sustained Relea…

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version